Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | increases expression | EXP | | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of ZFP692 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of ZFP692 mRNA] | CTD | PMID:22206623 | 17beta-estradiol | decreases expression | ISO | Zfp692 (Rattus norvegicus) | 6480464 | Estradiol results in decreased expression of ZFP692 mRNA | CTD | PMID:35192832 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of ZFP692 mRNA | CTD | PMID:21570461 | 2,4-dinitrotoluene | affects expression | ISO | Zfp692 (Rattus norvegicus) | 6480464 | 2 and 4-dinitrotoluene affects the expression of ZFP692 mRNA | CTD | PMID:21346803 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | ZNF692 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ZNF692 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ZNF692 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | ZNF692 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ZNF692 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | decreases methylation | ISO | ZNF692 (Homo sapiens) | 6480464 | bisphenol S results in decreased methylation of ZNF692 gene | CTD | PMID:31601247 | 4,4'-sulfonyldiphenol | decreases expression | EXP | | 6480464 | bisphenol S results in decreased expression of ZFP692 mRNA | CTD | PMID:30951980 | 4-amino-2,6-dinitrotoluene | affects expression | ISO | Zfp692 (Rattus norvegicus) | 6480464 | 4-amino-2 and 6-dinitrotoluene affects the expression of ZFP692 mRNA | CTD | PMID:21346803 | 4-hydroxyphenyl retinamide | increases expression | EXP | | 6480464 | Fenretinide results in increased expression of ZNF692 mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | decreases expression | ISO | Zfp692 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of ZFP692 mRNA | CTD | PMID:30047161 | aconitine | increases expression | ISO | Zfp692 (Rattus norvegicus) | 6480464 | Aconitine results in increased expression of ZFP692 protein | CTD | PMID:33236894 | amitrole | decreases expression | ISO | Zfp692 (Rattus norvegicus) | 6480464 | Amitrole results in decreased expression of ZFP692 mRNA | CTD | PMID:30047161 | antirheumatic drug | increases expression | ISO | ZNF692 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of ZNF692 mRNA | CTD | PMID:24449571 | arsane | affects methylation | ISO | ZNF692 (Homo sapiens) | 6480464 | Arsenic affects the methylation of ZNF692 gene | CTD | PMID:25304211 | arsenic atom | affects methylation | ISO | ZNF692 (Homo sapiens) | 6480464 | Arsenic affects the methylation of ZNF692 gene | CTD | PMID:25304211 | atrazine | affects methylation | ISO | Zfp692 (Rattus norvegicus) | 6480464 | Atrazine affects the methylation of ZFP692 gene | CTD | PMID:28931070 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of ZFP692 mRNA | CTD | PMID:27195522 | benzo[a]pyrene | affects methylation | ISO | ZNF692 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of ZNF692 promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of ZFP692 mRNA | CTD | PMID:22228805 | bisphenol A | affects expression | ISO | Zfp692 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of ZNF692 mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of ZFP692 mRNA | CTD | PMID:32156529 | bisphenol A | multiple interactions | ISO | ZNF692 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of ZNF692 gene | CTD | PMID:31601247 | bisphenol A | increases expression | ISO | Zfp692 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of ZFP692 mRNA | CTD | PMID:34947998 | bisphenol A | decreases expression | ISO | Zfp692 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of ZFP692 mRNA | CTD | PMID:30816183 and PMID:35192832 | bisphenol F | multiple interactions | ISO | ZNF692 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ZNF692 mRNA | CTD | PMID:28628672 | caffeine | increases phosphorylation | ISO | ZNF692 (Homo sapiens) | 6480464 | Caffeine results in increased phosphorylation of ZNF692 protein | CTD | PMID:35688186 | cisplatin | increases expression | ISO | ZNF692 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of ZNF692 mRNA | CTD | PMID:27392435 | cisplatin | multiple interactions | ISO | ZNF692 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of ZNF692 mRNA | CTD | PMID:27392435 | copper atom | increases expression | ISO | Zfp692 (Rattus norvegicus) | 6480464 | Copper results in increased expression of ZFP692 mRNA | CTD | PMID:30556269 | copper(0) | increases expression | ISO | Zfp692 (Rattus norvegicus) | 6480464 | Copper results in increased expression of ZFP692 mRNA | CTD | PMID:30556269 | copper(II) sulfate | decreases expression | ISO | ZNF692 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of ZNF692 mRNA | CTD | PMID:19549813 | coumarin | decreases phosphorylation | ISO | ZNF692 (Homo sapiens) | 6480464 | coumarin results in decreased phosphorylation of ZNF692 protein | CTD | PMID:35688186 | dexamethasone | multiple interactions | ISO | ZNF692 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ZNF692 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ZNF692 mRNA | CTD | PMID:28628672 | doxorubicin | decreases expression | ISO | ZNF692 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of ZNF692 mRNA | CTD | PMID:29803840 | elemental selenium | multiple interactions | ISO | ZNF692 (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in decreased expression of ZNF692 mRNA | CTD | PMID:19244175 | folic acid | multiple interactions | EXP | | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of ZFP692 mRNA] | CTD | PMID:22206623 | folic acid | decreases expression | EXP | | 6480464 | Folic Acid results in decreased expression of ZFP692 mRNA | CTD | PMID:25629700 | fulvestrant | multiple interactions | ISO | ZNF692 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of ZNF692 gene | CTD | PMID:31601247 | indometacin | multiple interactions | ISO | ZNF692 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ZNF692 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ZNF692 mRNA | CTD | PMID:28628672 | methimazole | decreases expression | ISO | Zfp692 (Rattus norvegicus) | 6480464 | Methimazole results in decreased expression of ZFP692 mRNA | CTD | PMID:30047161 | pregnenolone 16alpha-carbonitrile | decreases expression | ISO | Zfp692 (Rattus norvegicus) | 6480464 | Pregnenolone Carbonitrile results in decreased expression of ZFP692 mRNA | CTD | PMID:30047161 | selenium atom | multiple interactions | ISO | ZNF692 (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in decreased expression of ZNF692 mRNA | CTD | PMID:19244175 | tetraphene | affects expression | EXP | | 6480464 | benz(a)anthracene affects the expression of ZFP692 mRNA | CTD | PMID:26377693 | thalidomide | multiple interactions | ISO | ZNF692 (Homo sapiens) | 6480464 | Thalidomide results in increased degradation of and results in decreased expression of ZNF692 protein | CTD | PMID:30067223 | thioacetamide | decreases expression | ISO | Zfp692 (Rattus norvegicus) | 6480464 | Thioacetamide results in decreased expression of ZFP692 mRNA | CTD | PMID:34492290 | trichostatin A | affects expression | ISO | ZNF692 (Homo sapiens) | 6480464 | trichostatin A affects the expression of ZNF692 mRNA | CTD | PMID:28542535 | triptonide | decreases expression | EXP | | 6480464 | triptonide results in decreased expression of ZFP692 mRNA | CTD | PMID:33045310 | valproic acid | decreases expression | ISO | ZNF692 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of ZNF692 mRNA | CTD | PMID:22083351 and PMID:23179753 | vincristine | decreases expression | ISO | ZNF692 (Homo sapiens) | 6480464 | Vincristine results in decreased expression of ZNF692 mRNA | CTD | PMID:23649840 | vitamin E | multiple interactions | ISO | ZNF692 (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in decreased expression of ZNF692 mRNA | CTD | PMID:19244175 | vitamin E | decreases expression | ISO | ZNF692 (Homo sapiens) | 6480464 | Vitamin E results in decreased expression of ZNF692 mRNA | CTD | PMID:19244175 | vorinostat | decreases expression | ISO | ZNF692 (Homo sapiens) | 6480464 | vorinostat results in decreased expression of ZNF692 mRNA | CTD | PMID:22083351 | |